Delivery Order SPE2DB24D1205-SPE2DB25FCTWL
Award Date
2/10/25
Potential Completion Date
2/11/25
Potential Value
$15K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,562,473,545 units of Ondansetron HCL 8 mg tablets, a medication commonly used to treat nausea and vomiting. The contract has a total ceiling value of $14,200.58 and is a firm fixed-price contract with an ultimate completion date of October 16, 2023. The contract is not designated...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,116.51 contract is for the supply of 4,559,438,684 units of Ondansetron HCL 4 mg tablets. The contract has a period of performance through December 22, 2022 and was awarded on December 21, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,178.92, is for the delivery of 4,562,459,098 units of Ondansetron HCL 4 mg tablets, a medication commonly used to treat nausea and vomiting. The contract has an ultimate completion date of October 13, 2023 and is a firm fixed-price delivery order, with no...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,563,093,192 units of Ondansetron HCL 8 mg tablets, a medication used to prevent nausea and vomiting. The $2,958.33 firm-fixed-price contract has a completion date of December 14, 2023 and is not designated as a set-aside. AmerisourceBergen holds a larger $999,999,999...
This is a $23,766.18 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,566,930,860 units of ondansetron orally disintegrating 4 mg tablets, which are used to treat nausea and vomiting. The contract has an ultimate completion date of January 15, 2025 and was awarded on January 14, 2025. Amerisourcebergen holds a larger $999,999,999...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,562,791,665 units of Ondansetron ODT 4 mg tablet, a medication used to prevent nausea and vomiting. The contract has a ceiling value of $14,817.60 and an ultimate completion date of November 14, 2023. No set-aside designation was used for...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Ondansetron HCL 4 mg tablets, a medication used to prevent nausea and vomiting. The contract has a ceiling value of $10,072.72 and an ultimate completion date of February 5, 2025. It is a Firm Fixed Price contract with no set-aside designation, indicating open competition. Amerisourcebergen holds a larger...
This federal contract award, valued at $17,009.53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,565,665,266 units of Ondansetron HCL 4 mg tablets, a medication used to prevent nausea and vomiting. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of September 4, 2024. It is not designated as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,741.12, is for the delivery of 4,567,222,353 units of the drug Ondansetron HCL 4 MG tablets. The contract has a period of performance through February 11, 2025 and utilizes a Firm Fixed Price pricing type. This contract is not designated as a set-aside and was awarded under an Indefinite...
This is a delivery order placed by the Defense Logistics Agency (DLA) under an Indefinite Delivery Contract (IDC) with Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,566,571,391 tablets of 4 mg Ondansetron Hydrochloride, a medication used to treat nausea and vomiting. The delivery order has a ceiling value of $1,464.35 and a completion date of December 2, 2024. Amerisourcebergen holds a $999,999,999 IDC with the DLA Troop Support Medical...